• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Our Next Stock Pick
  • About Stocktrades
  • Meet Our Team
  • Contact Us
  • Login To Premium

Stocktrades

Stock Research | Stock Advice | Investing News

You May Have Seen Us On:

  • Stock News
    • Earnings Reports
    • TSX News
    • Bank Stocks
    • Cannabis Stocks
    • Energy Stocks
    • Material Stocks
    • Tech Stocks
    • Utility Stocks
    • Transportation Stocks
    • Manufacturing Stocks
  • Investing
    • How To Buy Stocks In Canada
  • Top Stocks
  • ETFs
  • Find Strong Stocks
  • Build A Perfect Portfolio
You are here: Home / Stock News / CannTrust (TSX:TRST) – Is it Game Over?

CannTrust (TSX:TRST) – Is it Game Over?

Last Updated : September 18, 2019 at 8:02 am By Mathieu Litalien Filed Under: Cannabis Stocks, Stock News

It was inevitable. Late Tuesday, Health Canada announced that it was suspending CannTrusts’ (TSX:TRST) licence to grow and process marijuana.

After months of uncertainty, and as new information came to light, the outcome was largely expected. Once one of the most trusted and respected companies in the industry, the company was caught breaking all kinds of rules.

From illegal production to insider trading and recent reports of supplying cannabis to the black market, CannTrust has been hit with a litany of charges.

The suspension is notable as it is the most severe penalty imposed on a cannabis company to date. Under the terms of the suspension, it can cultivate and harvest existing crops, but new growth and production is off limits. As is the selling of cannabis.

As per a company release “The notice constitutes a partial suspension of the company’s licence for standard cultivation and a full suspension of its licences for standard processing, medical sales, cannabis drugs and research”.

Despite the negative news, CannTrust also pointed out that Health Canada left the door open for the company’s licenses to be reinstated if it met certain conditions. The company said all the right things, but it will be little comfort to investors.

CannTrust’s share price plummets

After the news broke, its share price plummeted and closed at an all-time low of $1.70 per share, down 15% on the day. Over the past year, CannTrust has lost 85% of its value. At this point, not a single retail investor is in the black. Anyone who has bought into the company post IPO is sitting on losses.

We’ve warned investors several times over the past few months not to catch this falling knife. The risk to reward profile just wasn’t attractive. It still isn’t.

If the company can’t produce or sell cannabis, then bankruptcy is a real possibility. If you are still holding on to your shares in anticipation of a buyout, don’t expect to recoup a any significant portion of your investment.

If a White Knight was to emerge at this stage of the game, any offers are likely to be opportunistic in nature. They will look to acquire CannTrusts’ assets for pennies on the dollar.  

Likewise, the company is still facing a slew of potential litigations. The company remains under investigation by the Serious Offences Team of the Enforcement Branch of the OSC. This is a joint RCMP and OPP Anti-Rackets branch joint task force. Not to mention, there are several shareholder class action lawsuits under way.

Is it game over for CannTrust? The finish line is certainly in the line of sight.

Tagged With: CannTrust | TSX:TRST

Reader Interactions

About Mathieu Litalien

Mathieu is an individual investor and has been investing part-time for the better part of the past 20 years. He is primarily interested in fundamental analysis, focusing on the long-term and his portfolio is composed primarily of dividend-paying equities. Mathieu has a moderate risk profile and also looks for growth and value. His passion for finance and the markets have led him to his MBA and writing for Seeking Alpha, Motley Fool and Stocktrades. Mathieu also focuses primarily on stock research and content production for Stocktrades.ca Premium and the Stocktrades blog.
Connect With Me:

Primary Sidebar

Our Most Popular Posts:

How To Buy Stocks In Canada

35 Of The Best Canadian Stocks

35 Of The Best Dividend Stocks In Canada

How To Trade Penny Stocks In Canada

Questrade Review ($50 Promo Code Inside)

6 Canadian Blue Chip Stocks For 2020

Our Most Recent Posts:

WIll TD Bank (TSX:TD) Benefit from recent news?

Will the TD Ameritrade Deal Benefit TD Bank (TSX:TD) Investors? 

November 26, 2019 By Mathieu Litalien

On Monday, one of the worst kept secrets became official – Toronto-Dominion Bank (TSX:TD) announced it was selling its stake in TD Ameritrade as part of Charles Schwab’s $26 billion … [Read More...] about Will the TD Ameritrade Deal Benefit TD Bank (TSX:TD) Investors? 

  • Is Canadian Tire (TSX:CTC.A) Ready to Break Out?
  • Is Bausch Health (TSX:BCH) a Buy After Strong Earnings?
  • Should You Be Buying Kinaxis (TSX:KXS) After Earnings?
  • Encana (TSX:ECA) Files Earnings, Plans To Move To US
  • Shopify (TSE:SHOP) Files Third Quarter Earnings Miss
  • Is Tim Hortons Dragging Restaurant Brands International (TSX:QSR) Down?

Footer

About Us:

  • About Stocktrades
  • Meet The Stocktrades Team
  • Terms Of Service
  • Privacy Policy
  • Contact Us

How To Guides:

  • Buying Penny Stocks
  • How To Buy Stocks
  • Our Questrade Review

Stock Research:

  • Canadian Tech Stocks
  • Canadian Gold Stocks
  • Canadian Bank Stocks
  • Canadian Oil Stocks
  • Monthly Dividend Stocks

Stock Research:

  • Canadian Dividend Stocks
  • Canadian Growth Stocks
  • Canadian Utility Stocks
  • Blue Chip Stocks
  • Canadian Dividend Aristocrats
  • Canadian Small Cap Stocks

Address:

Stocktrades Ltd
#408 930 18th Ave SW
Calgary, Alberta T2T 0H1

Contact information:

E-mail: [email protected]
Phone: 1-403-827-0226

Copyright © 2019 Stocktrades Ltd. All Rights Reserved.
About Us:
Stocktrades.ca was founded in 2016 by investors Daniel Kent and Dylan Callaghan, with the ultimate goal of providing Canadian investors with the best possible tools to increase their investment portfolios. In an industry plagued with misinformation, our main priority is to maintain complete objectivity and bring investors around the world accurate, timely and high quality investment news and information.
DISCLAIMER:
Stocktrades is an independent media portal covering the development related to stocks on the TSX. However, Stocktrades is by no means associated with the Toronto Stock Exchange, or any of the companies we cover. All content on Stocktrades is the views of the individual reporters. Stocktrades offers strictly investment opinions, not investment advice. It is important to seek out a qualified investment, tax or legal professional before making any decisions related to your own personal investments. The information on Stocktrades.ca represents the views of the authors and should not be misconstrued as advice.